Evidence-Based Medicine Guidelines
Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer is a topic covered in the Evidence-Based Medicine Guidelines.
To view the entire topic, please log in or purchase a subscription.
Evidence Central is an integrated web and mobile solution that helps clinicians quickly answer etiology, diagnosis, treatment, and prognosis questions using the latest evidence-based research. Explore these free sample topics:
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Ovarian Suppression for Adjuvant Treatment of Hormone Receptor‐positive Early Breast Cancer." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/_________Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor���positive_early_breast_cancer______.
Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/_________Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor���positive_early_breast_cancer______. Accessed March 20, 2023.
Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/_________Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor���positive_early_breast_cancer______
Ovarian Suppression for Adjuvant Treatment of Hormone Receptor‐positive Early Breast Cancer [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2023 March 20]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/_________Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor���positive_early_breast_cancer______.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Ovarian suppression for adjuvant treatment of hormone receptor‐positive early breast cancer
ID - 1305349
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/1305349/all/_________Ovarian_suppression_for_adjuvant_treatment_of_hormone_receptor���positive_early_breast_cancer______
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
